Heights Capital Management, Inc
Source: SEC Form 13F · as of Mar 2026Heights Capital Management, Inc holds 10 biotech & pharma companies tracked by BioSniper, totaling $22.1M in value as of Mar 2026 (SEC Form 13F).
Companies held
10
Total value held
$22.1M
| Company | Shares | Value |
|---|---|---|
| CMPSCOMPASS Pathways plc | 1,492,415 | $8.3M |
| CCXIChemoCentryx, Inc. | 448,176 | $4.6M |
| CADLCandel Therapeutics, Inc. | 775,000 | $3.8M |
| SCYXSCYNEXIS INC | 2,086,960 | $1.9M |
| IMDXInsight Molecular Diagnostics Inc. | 392,545 | $1.3M |
| IPEXInflection Point Acquisition Corp. V | 100,000 | $1.0M |
| PMNProMIS Neurosciences Inc. | 50,660 | $643K |
| MODDModular Medical Inc. | 50,000 | $264K |
| CMIIUColumbus Circle Capital Corp II Unit | 25,000 | $249K |
| BCTXZBriaCell Therapeutics Corp. | 540,098 | $76K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.